Millions of people worldwide suffer from liver inflammation (hepatitis), an acute or chronic disease with a variety of causes. Liver inflammation frequently occurs in connection with metabolic disorders, for example fatty liver disease. Lysomal acid lipase (LAL) deficiency is a rare metabolic disorder that also causes liver inflammation.
Rare metabolic disorder can cause liver inflammation retrieved 6 August 2024 from https://medicalxpress.com/news/2024-08-rare-metabolic-disorder-liver-inflammation.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.Use this form if you have come across a typo, inaccuracy or would like to send an edit request for the content on this page. For general inquiries, please use ourThank you for taking time to provide your feedback to the editors.
Your feedback is important to us. However, we do not guarantee individual replies due to the high volume of messages.to let the recipient know who sent the email. Neither your address nor the recipient's address will be used for any other purpose. The information you enter will appear in your e-mail message and is not retained by Medical Xpress in any form.Get weekly and/or daily updates delivered to your inbox.
Medicine Research Health Research News Health Research Health Science Medicine Science
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Research supports TCM liver-breast cancer theory: Fatty liver linked to deteriorating breast cancerA research team from the School of Chinese Medicine, LKS Faculty of Medicine, the University of Hong Kong (HKUMed) has made a remarkable discovery that patients with non-alcoholic fatty liver disease (commonly known as fatty liver disease) exhibit excessive production of a hepatokine called Fibroblast Growth Factor 21 (FGF21) in their liver, which...
Read more »
Study finds targeting inflammation may not help reduce liver fibrosis in metabolic-associated fatty liver diseaseResearchers at UCLA Health uncovered new information about the role inflammation plays in mitigating liver fibrosis, which is associated with metabolic-associated fatty liver disease (MAFLD), one of the most common diseases in the world affecting up to 40% of U.S. adults.
Read more »
Liver transplant outperforms other therapies for colorectal cancer that has spread to the liverColorectal cancer often spreads to the liver, and for some patients, surgical removal of their liver tumors is not an option.
Read more »
Using microphysiological systems to investigate fatty liver disease and drug-induced liver injury (DILI)This article explains how microphysiological systems can be used for research on fatty liver disease and assessing the risk of drug-induced liver injury
Read more »
Alcoholic liver disease in China: A disease influenced by complex social factors that should not be neglectedAlcoholic liver disease (ALD) is a major cause of liver-related morbidity and mortality globally. Chronic alcohol consumption, a primary driver of ALD, leads to a spectrum of liver conditions ranging from fatty liver to cirrhosis and hepatocellular carcinoma.
Read more »
Diabetes and obesity can cause liver failure—but few people know their risk of developing liver diseaseLiver disease is frighteningly common worldwide.
Read more »